Long-term safety, tolerability, and efficacy of efgartigimod in patients with generalized myasthenia gravis: Concluding analyses from the ADAPT+ study

Results

Title:	Long-term safety, tolerability, and efficacy of efgartigimod in patients with generalized myasthenia gravis: Concluding analyses from the ADAPT+ study
Authors :	Bril, Vera; ...; Perić, Stojan Z. ; ...; (broj koautora 17)
Issue Date:	2023
Publication:	Journal of the neurological sciences (Abstracts from the 26th World Congress of Neurology (WCN), Oct 15-19, 2023, Montreal, Canada)
ISSN:	0022-510X Journal of the Neurological Sciences Search Idenfier
Publisher:	Amsterdam : Elsevier
Type:	Conference Paper
Collation:	vol. 455 br. Suppl str. 20-21
DOI:	10.1016/j.jns.2023.121089
WoS-ID:	001163199100219
URI:	https://enauka.gov.rs/handle/123456789/898745
URL:	https://www.sciencedirect.com/science/article/pii/S0022510X23005506?via%3Dihub
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Altmetric

Dimensions

Unpaywall

Google Scholar^TM